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0022-2836 © 2010 Elsevier Ltd. Open accThe Wnt pathway tumor-suppressor protein Axin coordinates the
formation of a critical multiprotein destruction complex that serves to
downregulate β-catenin protein levels, thereby preventing target gene
activation. Given the lack of structural information on some of the major
functional parts of Axin, it remains unresolved how the recruitment and
positioning of Wnt pathway kinases, such as glycogen synthase kinase 3β,
are coordinated to bring about β-catenin phosphorylation. Using various
biochemical and biophysical methods, we demonstrate here that the central
region of Axin that is implicated in binding glycogen synthase kinase 3β
and β-catenin is natively unfolded. Our results support a model in which
the unfolded nature of these critical scaffolding regions in Axin facilitates
dynamic interactions with a kinase and its substrate, which in turn act upon
each other.© 2010 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
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ess under the Elsevier OA licentiation during embryonic development and in adult
tissue homeostasis.1 Inappropriate activation of the
Wnt pathway due to mutations is frequently linked
to the development of cancer.2 Molecular events in
the Wnt pathway converge on the regulation of the
protein levels of the transcriptional coactivator β-
catenin, which controls key developmental gene
expression programs.3
In the absence ofWnt ligand, the tumor-suppressor
protein Axin coordinates the formation of a multi-
protein complex composed of the scaffolding protein
adenomatous polyposis coli (APC) and the kinases
casein kinase 1 (CK1) and glycogen synthase kinase
3β (GSK3β).4–8 This protein complex efficiently
recruits and phosphorylates β-catenin on conserved
N-terminal serine and threonine residues, thereby
marking it for ubiquitin–proteasome-mediatedse.
Fig. 1. Domain organization of Axin. Well-defined Axin domains that are important for Wnt pathway regulation are
shown. The N-terminal RGS domain binds APC, and the C-terminal DIX domain is responsible for homodimerization
and heterodimerization. The central region (indicated as AxinCR), connecting the RGS and DIX domains, binds to GSK3β
and β-catenin. The experimental fragment AxinCRG295-A500 is indicated. Asterisks indicate the locations of missense
mutations in AxinCR reported in a variety of human tumors.18–22
774 Highly Flexible Scaffolding by Axin1degradation.9–15 Wnt binding to its receptors Frizzled
and Lrp5/6 at the cell surface results in the
recruitment of the Axin–GSK3β complex, which
now turns its activity to phosphorylate the cytoplas-
mic tail of Lrp6.16,17 Together, these events lead to an
accumulation of dephosphorylated β-catenin and its
migration to the nucleus to induce target gene
transcription.
Axin possesses multiple functional domains
through which it orchestrates β-catenin phosphor-
ylation (Fig. 1). The N-terminal RGS (regulator of
G-protein signaling) domain mediates binding to
the large scaffolding protein APC. APC itself
carries three short Axin binding motifs and
multiple binding sites for β-catenin.23 The C-
terminal DIX domain of Axin mediates self-
association and binding to the DIX domain of
Dishevelled, which is believed to modulate its
signaling activity.24–26 The central part of Axin
contains binding sites for GSK3β, β-catenin, and
CK1.5,27 Scaffolding of APC, GSK3β, and β-catenin
by Axin dramatically enhances GSK3β-mediated
phosphorylation of β-catenin.28,29 At the same
time, GSK3β-mediated phosphorylation of Axin
enhances its stability.30
While crystal structures are available for both
the RGS domain and the DIX domain of Axin,26,31
experimental structural information on the central
region of Axin (AxinCR) is limited to small helical
Axin peptides that were cocrystallized with
GSK3β and β-catenin.32,33 Insight into the struc-
tural properties of this region is crucial to
understanding how Axin coordinates protein–
protein interactions in the β-catenin destruction
complex to mediate its tumor-suppressor activity.
The functional importance of the Axin central
region is illustrated by an increasing number of
reported missense mutations in this part of the
protein in various tumors (Fig. 1).18–22
Using various biophysical and biochemical meth-
ods, we demonstrate here that the central domain of
Axin is intrinsically disordered. Our findings sup-port a model in which crucial scaffolding functions
of Axin are exerted by a large highly flexible region.
Results
Recombinant AxinCRG295-A500 is functional
in vitro and in vivo
Functional understanding of AxinCR, which con-
nects the folded N-terminal RGS domain and the C-
terminal DIX domain (Fig. 1), is limited due to a lack
of experimental structural information. To determine
the structural properties of AxinCR in an experimen-
tal approach, we generated and purified a recombi-
nant fragment of AxinCR spanning Gly295 to Ala500
and including the GSK3β-binding domain and the β-
catenin bindingdomain. First, we set out to determine
if AxinCRG295-A500, lacking the N-terminal RGS
domain and the C-terminal DIX domain of Axin, is
functional in isolation. We recombinantly produced
GSK3β as His-tagged NusA fusion protein (to
increase solubility) and His-tagged β-catenin. Both
His-NusA-tagged GSK3β and His-tagged β-catenin,
but not control His-NusA protein, were able to bind
AxinCRG295-A500 in a pull-down approach (Fig. 2a–c).
To verify that this interaction also takes place in vivo,
we expressed glutathione S-transferase (GST)-tagged
AxinCRG295-A500 in HEK293T cells and confirmed its
binding to endogenous GSK3β and β-catenin (Fig.
2d). These results are consistent with current models,
which propose that AxinCR is able to perform its
scaffolding function by bringing together kinase and
substrate. In addition, ectopic expression of the GST-
taggedAxinCRG295-A500 fragment inmammalian cells
strongly induced β-catenin-mediated transcription in
a luciferase reporter assay (TOPflash),34 whereas the
GST-tagged full-length Axin protein fully suppresses
Wnt-induced activation (Fig. 2e). These findings
suggest that the AxinCRG295-A500 fragment competes
with endogenous Axin (estimated ratio, 50:1) for
binding to GSK3β and β-catenin, and dominantly
Fig. 2. AxinCRG295-A500 binds GSK3β and β-catenin, and hyperactivates the Wnt pathway through activation of β-
catenin. (a–c) AxinCRG295-A500 forms a complex with GSK3β and β-catenin. His-NusA-GSK3β, His-β-catenin N138-L781,
or His-NusA (lane 1; input) was incubated with purified AxinCRG295-A500 (lane 2; input). Protein complexes were isolated
with Ni-NTA beads in a pull-down assay. Flow-through (FT; lane 3), wash (lanes 4–8), and eluted (lanes 9–12) fractions
are shown. AxinCRG295-A500 coelutes with His-NusA-GSK3β (a) and His-β-catenin (b), but not with the tag protein His-
NusA (c). (d) Lysates from HEK293T overexpressing GST or GST-AxinCRG295-A500 were incubated with GST beads.
Endogenous β-catenin and GSK3β coelute with GST-AxinCRG295-A500, but not with GST alone. (e) TOPflash luciferase
reporter activity induced in HEK293T cells expressing the control vector, GST-tagged full-length Axin (AxinFL), or GST-
AxinCRG295-A500. Cells were treated with β-catenin or control siRNA, and with WCM (+WCM) or control medium
(−WCM), as indicated. Relative TOPflash/FOPflash luciferase ratios (±SD) of duplicate experiments are shown. Results
represent at least three independent experiments. (f) Expression levels of β-catenin, AxinFL, AxinCRG295-A500, and tubulin
in the presence or in the absence of siRNA against β-catenin. (g) Quantification of β-catenin expression levels normalized
against tubulin.
775Highly Flexible Scaffolding by Axin1interferes with the formation of a functional endog-
enous destruction complex. As a consequence, β-
catenin accumulates and translocates to the nucleus to
initiate the transcription of the luciferase reporter
gene. In concordance, TOPflash reporter activity isinduced by AxinCRG295-A500 in a Wnt-independent
manner (Fig. 2e).
To verify that the TOPflash activity enhanced by
AxinCRG295-A500 expression in cells depends on the
activation of β-catenin, we performed the TOPflash
Fig. 3. AxinCRG295-A500 does not
undergo temperature-induced
unfolding. (a) Fluorescence spectra
of AxinCRG295-A500 measured at
low (21 °C) and high (79 °C) tem-
peratures. Maximal spectral inten-
sities were equalized for both
temperatures to allow for a com-
parison of peak shifts. (b) Fluores-
cence intensity of AxinCRG295-A500
during a stepwise temperature in-
crease ranging from 21 °C to 79 °C
at 352 nm. Fluorescence intensity
values were normalized against
values obtained at 20 °C. (c) Fluo-
rescence spectra of AxinRGS mea-
sured at low (22 °C) and high
(72 °C) temperatures. (d) Fluores-
cence intensity of AxinRGS during
a stepwise temperature increase
ranging from 22 °C to 72 °C at
340 nm. The mean values of three
measurements are shown.
776 Highly Flexible Scaffolding by Axin1assay in the presence of small interfering RNA
(siRNA) oligonucleotides that silence β-catenin
expression (Fig. 2e). siRNA treatment for 48 h
reduces endogenous β-catenin expression levels to
30% (Fig. 2f and g) and abrogates TOPflash activity in
the presence or in the absence of AxinCRG295-A500, as
well as upon addition ofWnt3a-conditioned medium
(WCM). These results argue that AxinCRG295-A500
retains its GSK3β and β-catenin binding functions
independent of the rest of the protein in vivo and
in vitro.
AxinCRG295-A500 does not undergo thermal
denaturation and displays an extended
conformation
To determine whether AxinCRG295-A500 carries a
three-dimensionally folded hydrophobic core, we
performed thermal denaturation studies by moni-
toring intrinsic protein (Trp-mediated) fluorescence
as a measure of tertiary structural changes. Two
Trp residues are present in AxinCRG295-A500 (W297
and W444). We monitored the fluorescence spec-
trum of AxinCRG295-A500 while raising the temper-
ature from 20 °C to 80 °C (Fig. 3a and b). Thefluorescence intensity of AxinCRG295-A500 peaked at
similar wavelengths at minimal and maximal
temperatures (Fig. 3a). In concordance, the thermal
denaturation curve of AxinCRG295-A500 did not
reveal a transition in fluorescence intensity (Fig.
3b). In contrast, a recombinantly produced Axin
RGS domain, which is known to exist in a tightly
folded conformation,31 significantly shifts in peak
fluorescence intensity when comparing minimal
and maximal temperatures (Fig. 3c). Moreover, the
RGS domain yielded a clear transition in fluores-
cence intensity during thermal denaturation, reflect-
ing an unfolding of the hydrophobic core (Fig. 3d).
These findings indicate that AxinCRG295-A500, in
contrast to the Axin RGS domain, lacks folded
domains with a hydrophobic core, or that the two
Trp residues in the AxinCRG295-A500 sequence are
not inside any folded region. To assess whether
AxinCRG295-A500 lacks a hydrophobic core and
consequently adopts an extended shape, we per-
formed analytical size-exclusion chromatography
(Fig. 4a). AxinCRG295-A500 eluted from the column
with an elution volume of 9.92 ml. According to the
calibration curve of standard markers, this volume
corresponds to a molecular mass of 70 kDa, a value
Fig. 4. AxinCRG295-A500 displays an
extended structure. (a)AxinCRG295-A500
was applied on a Bio-Silect SEC
analytical column. The elution vol-
ume of AxinCRG295-A500 is 9.92 ml
and corresponds to amolecularmass
of 70 kDa, which is approximately
three times the calculated molecular
mass of 23 kDa. (b) AxinCRG295-A500
does not self-interact. Purified His-
tagged AxinCRG295-A500 (lane 1;
input) was incubated with untagged
AxinCRG295-A500 (lane 2; input). Subse-
quently, His-tagged AxinCRG295-A500
was isolated with Ni-NTA beads in a
pull-down assay. AxinCRG295-A500was
abundantly detected inunboundwash
fractions but did not coelute with His-
tagged AxinCRG295-A500 (lanes 8–10),
indicating a lack of self-association.
777Highly Flexible Scaffolding by Axin1that is significantly higher than the calculated mass
of 23 kDa based on the primary amino acid sequence.
The large apparent size of AxinCRG295-A500 during
size-exclusion chromatography could be attributed
to either an unfolded extended shape or oligomer-
ization. To exclude the latter possibility, we
analyzed whether His-tagged AxinCRG295-A500
could bind the untagged form by utilizing a pull-
down assay. We could not detect any interaction
between the two AxinCRG295-A500 forms (Fig. 4b).
These findings rule out the possibility that
AxinCRG295-A500 forms oligomers and support the
assumption that AxinCRG295-A500 bears an extended
conformation lacking a hydrophobic core.
AxinCRG295-A500 exhibits a random-coil secondary
structure with residual helical elements
Next, we applied circular dichroism (CD) to gain
insight into the presence of secondary structural
elements in AxinCRG295-A500. The far-UV CD spec-
trum yielded a negative peak of ellipticity at 201 nm,
a typical feature of random-coil structures35 (Fig. 5).
To uncover whether residual helical elements in the
AxinCRG295-A500 fragment could be induced, we
titrated increasing amounts of 2,2,2-trifluoroethanol
(TFE), a helix-stabilizing agent that only acts on
proteins that carry residual unstable helical structures
by strengthening local H-bond interactions.36 Addi-
tion of TFE shifted the negative peak to 208 nm and
induced another negative peak at 222 nm and a
positive peak at 190 nm, yielding a spectrum of aprotein with significant α-helical content (Fig. 5).
With the use of CD deconvolution algorithms
(DichroWeb37), the α-helical content of Axin is
estimated to be 21% under physiological conditions
and increases to 58% under conditions of 20% TFE.
These results indicate that AxinCRG295-A500 has the
tendency to formα-helical elements that are stabilized
by conditions favoring intramolecular interactions.
AxinCR is predicted to lack order
To gain insight into the localization of helical
elements and the overall structural organization of
AxinCRG295-A500 (Fig. 6a), we utilized bioinformatic
tools to predict secondary structure binding
sites and disorder tendency. We submitted the
AxinCRG295-A500 protein sequence to eight publicly
available servers that predict secondary structure
based on the primary sequence and to seven servers
that predict protein disorder, implementing 12
algorithms (Fig. 6c and d). The chosen algorithms
for disorder prediction were based on different
criteria (reviewed by Ferron et al.38).
Individual prediction programs for secondary
structure consistently predict three helical regions,
two of which overlap with α-helical peptides
previously cocrystallized in complex with GSK3β
and β-catenin, respectively (Fig. 6c and d).32,33 In
contrast, the predicted extent of disordered regions
is inconsistent, differing significantly between algo-
rithms (Fig. 6d). Noticeably, the amino acid compo-
sition of AxinCRG295-A500 reveals 52.8% disorder-
Fig. 5. AxinCRG295-A500 displays a random-coil confor-
mation with residual α-helical elements. Far-UV CD
spectrum of AxinCRG295-A500 in 10 mM phosphate buffer
(pH 7.2), 50 mM NaF, and 0.5 mM TCEP. The spectra
show a negative peak at 201 nm, which corresponds to a
random-coil conformation. Titration of TFE induces a
change in the spectrum, yielding negative peaks at 208 nm
and 220 nm and a positive peak at 190 nm, characteristic of
a protein containing α-helices.
778 Highly Flexible Scaffolding by Axin1promoting residues (D, M, K, R, S, Q, P, and E) and
33.7% order-promoting residues (C, W, Y, I, F, V, L,
H, T, and N); in comparison, for the folded RGS
domain, the respective fractions compose 44.4% and
45.2%.39 Together with our experimental data, these
predictions argue that AxinCR is unfolded while
containing three short helices, which might only be
stabilized by cofactors in the cell. As two of these
helices perform protein–protein interactions and do
not contain hydrophobic patches on their surface,
we consider it unlikely for the three helical modules
to form a hydrophobic core.
1H–15N heteronuclear single-quantumcoherence
NMR spectrum of AxinCRG295-A500 reveals an
unstructured conformation
To gain insight into the tertiary structure of
AxinCR, we performed two-dimensional 1H–15N
heteronuclear single-quantum coherence (HSQC)
NMR analysis (Fig. 7). The resulting HSQC spec-
trum showed strongly clustered resonances in a
narrow range of 7.6–8.6 ppm, which is characteristic
of unfolded proteins.40 To compare the properties of
AxinCRG295-A500 in physiological buffer with an
entirely unfolded AxinCRG295-A500, we repeated thetwo-dimensional 1H–15N HSQC NMR experiment
in the presence of the denaturing agent urea. Both
spectra reveal only minor differences, which most
likely are caused by an increase in buffer viscosity
upon addition of 5 M urea.41 These results confirm
that AxinCRG295-A500 is intrinsically disordered
under physiological conditions.
AxinCRG295-A500 strongly enhances the
GSK3β-mediated phosphorylation of β-catenin
To address the scaffolding role of AxinCRG295-A500,
we incubatedGSK3βwith a fixed amount ofβ-catenin
substrate and titrated purified AxinCRG295-A500 in
this reaction. Titration of AxinCRG295-A500 strongly
enhanced the efficiency of GSK3β in phosphory-
lating β-catenin in vitro (Fig. 8a), whereas no effect
was observed on AxinCR variants lacking either
the β-catenin binding site (AxinCRΔβcat) or the
GSK3β binding site (AxinCRΔGSK3β), suggesting
that Axin binding of both GSK3β and β-catenin is
required for its scaffolding function (Fig. 8b and c).
Phosphorylation of the AxinCRG295-A500 and
AxinCRΔβcat fragments occurs equally well (Fig.
8a and b), suggesting that both variants adequately
bind GSK3β. In contrast, AxinCRΔGSK3β remains
largely unphosphorylated (Fig. 8c), confirming a
lack of GSK3β binding. Quantification of β-catenin
phosphorylation levels in these experiments demon-
strates that the enhancement of β-catenin phosphor-
ylation reaches a plateau and drops upon further
titration of AxinCRG295-A500 (Fig. 8d). These findings
suggest the need for the formation of a trimolecular
complex to most efficiently achieve β-catenin
phosphorylation. AxinCRG295-A500 excess likely
titrates GSK3β away from β-catenin, thereby dimin-
ishing the efficiency of phosphorylation (Fig. 8e). We
conclude that the highly flexible AxinCRG295-A500
fragment scaffolds and targets GSK3β kinase
activity towards its substrate, β-catenin.Discussion
The tumor-suppressor protein Axin plays a crucial
role in the control of Wnt signaling by coordinating
the formation of amultiprotein complex thatmediates
the phosphorylation of the transcriptional regulator
β-catenin.4 The N-terminal RGS domain and the C-
terminal DIX domain assist in the assembly of the
complex by binding the scaffolding protein APC and
by mediating Axin oligomerization, respectively,
whereas AxinCR brings together the kinases CK1
and GSK3β and their substrate, β-catenin.4 The
structures of the RGS and DIX domains were solved
previously,26,31 but as of yet, the tertiary structure of
the connecting and functionally important middle
part ofAxin has just been predicted to be disordered42
and has not adequately been addressed.
Fig. 6. Schematic representation
of the structural characteristics of
AxinCRG295-A500. (a) Schematic rep-
resentation of AxinCRG295-A500. (b)
Schematic representation of the two
α-helical Axin peptides cocrystal-
lizedwithGSK3β32 andβ-catenin.33
(c) Secondary structure predictions
for AxinCRG295-A500 were per-
formed using eight algorithms in
publicly available servers. Bars rep-
resent the predicted secondary
structure elements of different algo-
rithms. Segments that are predicted
to be α-helical are indicated in red.
(d) Disorder predictions for
AxinCRG295-A500 were performed
using 12 algorithms in publicly
available servers. Bars represent
predicted disorder according to
different algorithms, as indicated.
Segments that are predicted to be
disordered are depicted in blue.
779Highly Flexible Scaffolding by Axin1Here, we have used a variety of biophysical and
biochemical techniques to analyze the conformation
of AxinCR. Our results convincingly show that the
large AxinCR is intrinsically disordered under
physiological conditions. Despite the clear lack of
rigid tertiary structure in AxinCR, residual helical
elements may be present, as shown by CD analysis.
The unstable interconverting helical elements are
stabilized by conditions that favor intramolecular
hydrogen-bond formation (Fig. 5). In accordance
with these findings, two independent AxinCR
peptides that were cocrystallized with GSK3β32
and β-catenin33 showed α-helical conformation.
Together, these results argue that residual helical
regions in unbound AxinCR may be stabilized with
their interaction partners during complex formation.
Indeed, disorder-to-order transitions that accompa-
ny the molecular recognition of disordered proteins
are reported in an increasing number of cases.39,42–44
The rudimentary presence of helices in the confor-
mational equilibrium would also allow recruitment
of partner proteins via conformational selection.45How does the large intrinsically disordered region
facilitate the multiple roles of Axin in different and
crucial developmental signaling pathways? Besides
mediating β-catenin phosphorylation, the middle
part of Axin accommodates multiple additional
protein–protein interactions, the majority of which
act in important signaling pathways [e.g., trans-
forming growth factor β, c-Jun N-terminal kinase
(JNK), and p53]46–51 (Fig. 9). Several of the binding
sites of these interaction partners overlap. It remains
unresolved how Axin, typified as the limiting
component of the β-catenin destruction complex,52
may serve various functions in the cell. To meet this
requirement, the intrinsically disordered propensity
of AxinCR would provide a highly flexible and
extended surface for interactions of low affinity and
high specificity42 (Fig. 9). As a consequence,
implicated protein interactions are fast and tran-
sient. For specificity to be secured, selective induc-
tion of (partial) folding or secondary structure
formation by interacting proteins may serve to
shape the conformation of the disordered region to
Fig. 7. AxinCRG295-A500 is predominantly unfolded. The
1H–15N HSQC spectrum of AxinCRG295-A500 in 10 mM
phosphate buffer (pH 7.2) with anionic-strength 300 mM
NaCl, 0.5 mM TCEP, 10% D2O, and 2.5% DSS is
represented in red. The fingerprint resonance from
amide protons of peptide bonds is not well dispersed
and ranges from 7.6 ppm to 8.5 ppm, reflecting an
unstructured conformation. The 1H–15N HSQC spectrum
of AxinCRG295-A500 in 10 mM phosphate buffer (pH 7.2)
with 300 mM NaCl, 0.5 mM TCEP, 10% D2O, 2.5% DSS,
and 5 M urea is represented in blue. The two spectra show
significant overlap, indicating a lack of structure of
AxinCR under physiological conditions.
780 Highly Flexible Scaffolding by Axin1the needs of one single signaling pathway at the
time.39,42–44 Hence, folding of disordered regions by
the binding of one binding partner at “site A”would
allosterically couple to the binding events of another
factor at “site B” (site-to-site communication).53 In
agreement with this hypothesis, two JNK pathway
factors, MEKK1 andMEKK4, compete for binding to
Axin, whereas their binding sites are located in
separate nonoverlapping regions in the unstruc-
tured middle part of Axin.54
The role of AxinCR in the Wnt pathway is to bring
the GSK3β kinase and its substrate, β-catenin, in
close proximity, thereby catalyzing the phosphory-
lation of the flexible β-catenin N-terminal tail.
Hence, Axin forces specificity on the broadly
involved GSK3β kinase to phosphorylate β-catenin.
Interestingly, the repeat regions in APC that bind
Axin and β-catenin are located in a predicted
natively disordered region as well.55 The
corresponding transient nature of multiple pro-
tein–protein interactions in the complex would
allow a rapid handover of the β-catenin substrate
from Axin to APC, from APC to the E3 ligase β-
transducin repeat-containing protein, and, finally, to
the proteasome.3 Of note, other functionally impor-
tant binding partners of β-catenin (e.g., E-cadherin
and Tcf) interact through extended unfolded protein
segments as well, suggesting the importance of
disordered domains in the regulation of a key
signaling pathway protein.56Mutations in Axin are strongly linked to the
development of cancer.18,19,57 Many missense muta-
tions, as reported in colorectal carcinoma, medullo-
blastoma, and hepatocellular carcinoma, hit
AxinCR18,19 (Fig. 1). Inhibition or downregulation
of the tumor-suppressor protein Axin is believed to
contribute to tumor formation.18 Regarding the lack
of structure of AxinCR, missense mutations are
unlikely to affect protein function and stability by
misfolding, but rather would interfere with the
binding of partner proteins to linear motifs, or may
disturb interaction due to conformational selection.
Remarkably, however, many of these mutations
affect residues outside the linear binding motifs for
β-catenin and GSK3β. How these mutations dereg-
ulate GSK3β activity towards β-catenin remains the
subject of further studies.
In summary, we demonstrate that the functionally
important AxinCR is natively unfolded under
physiological conditions. These findings bear im-
portance for our current study of the mechanism by
which Axin performs its tumor-suppressor function.Materials and Methods
Construct generation and protein expression
The fragments encompassing the central regions of
human Axin1, AxinCRG295-A500, AxinCRΔβcat (G295-
G430), and AxinCRΔGSK3β (G433-V600), as well as the
RGS domains of Axin (N2-V220), human β-catenin (full
length andN138-L781), and humanGSK3β, were amplified
by PCR. All AxinCR fragments were cloned in the bacterial
expression vector pET-24a(+) (Novagen). pET-24a(+) was
modified by insertion of a six-histidine tag and a tobacco
etch virus (TEV) protease cleavage site (between NdeI and
EcoRI) to provide a cleavable tag at the N-terminus of the
fusedprotein.GSK3β,β-catenin, andAxinRGSwere cloned
in pET-50b(+) (Novagen). All proteins were expressed in
Escherichia coli Rosetta2 cells (Merck4Biosciences).
Cells expressing Axin fragments were grown in Luria–
Bertani medium. M9 minimal medium enriched with
15NH4Cl (Cambridge Isotope Laboratories, Inc.) was used
for NMR purposes. At the time point where the optical
density (OD600) had reached 0.6, protein expression was
induced by addition of 0.5 mM isopropyl β-D-1-thioga-
lactopyranoside (Roche). Bacterial cultures expressing all
AxinCR fragments and β-cateninN138-L781 were incubated
at 20 °C for 4 h, and cultures expressing AxinRGS were
incubated at 18 °C for 16 h.
Cells transformed with the β-catenin and GSK3β
constructs were grown in Terrific broth autoinduction
medium at 30 °C. At the time point where the OD600 had
reached 3, the temperature was decreased to 15 °C, and
the cells grew until the OD600 had reached 15.
Protein purification
Bacterial Rosetta cells expressing Axin fragments and β-
cateninN138-L781 were pelleted, resuspended in buffer A
Fig. 8. AxinCRG295-A500 facilitates the phosphorylation of β-catenin. In vitro phosphorylation of β-catenin by GSK3β in
the absence and in the presence of a titration series of (a) AxinCRG295-A500, (b) AxinCRΔβcat, and (c) AxinCRΔGSK3β. The
phosphorylation of Axin fragments is also shown. (d) Quantification of the 32P incorporation of β-catenin for all reactions
(a–c). The intensities were normalized against the value of the phosphorylated β-catenin in the absence of the Axin
fragment. (e) Model depicting the effects of low (left), moderate (middle), and high (right) abundances of AxinCRG295-A500
on GSK3β-mediated kinase activity towards β-catenin. Under optimal stoichiometric conditions (middle), the majority of
molecules are involved in trimolecular complex formation, providing the maximal phosphorylation of β-catenin. AxinCR
excess (right) inhibits the formation of complexes composed of all three proteins, leading to a decrease in phosphorylation
efficiency.
781Highly Flexible Scaffolding by Axin1[50 mM Tris–HCl (pH 7.5), 300 mM NaCl, 20 mM
imidazole, 0.5 mM tris(2-carboxyethyl)phosphine
(TCEP), and Complete Protease Inhibitor Cocktail
EDTA-Free Tablets (Roche)], and lysed by sonication
(Sonifier B12; Branson Ultrasonic). A subsequent ultracen-
trifugation step (30,000 rpm for 45 min at 4 °C) separated
the soluble proteins from the insoluble proteins. The
soluble fraction was filtered and applied to a POROS
20MC column (metal-chelate affinity chromatography;
Applied Biosystems) connected to an Äkta Purifier
chromatography system (GE Healthcare). The column
was equilibrated with 10 column volumes (CV) of buffer
A, and a linear gradient between and buffer A and buffer
B [50 mM Tris–HCl (pH 7.5), 300 mM NaCl, 1 M
imidazole, and 0.5 mM TCEP] was applied to elute His-
tagged proteins. Fractions were collected and analyzed by
SDS-PAGE. Appropriate fractions containing His-tagged
proteins were applied to a HiTrap desalting column (GE
Healthcare) to exchange buffer B with 50 mM Tris–HCl
(pH 7.5), 150 mM NaCl, and 0.5 mM TCEP. Recombinant
His-tagged TEV protease, which was modified to enhance
stability (L56V/S135G; the expression construct was akind gift of Cabrita et al.58), was added at a His-tagged
protein/TEV ratio of 8:1. Cleavage took place at 37 °C for
3 h in the presence of 1 mM dithiothreitol (DTT). Next, the
cleaved AxinCRG295-A500, AxinCRΔβcat, and AxinRGS
proteins were further purified by anion-exchange chro-
matography after a decrease of the salt concentration to
30 mM NaCl. A segmented gradient between equilibra-
tion buffer [50 mM Tris–HCl (pH 9) and 0.5 mM TCEP]
and elution buffer [50 mMTris–HCl (pH 9), 1 MNaCl, and
0.5 mM TCEP] eluted Axin fragments with 95% purity, as
determined by SDS-PAGE and Coomassie brilliant blue
G-250 (Serva) staining. AxinCRΔGSK3β was separated by
the TEV protease using a second affinity purification.
Bacterial cells expressing GSK3β and β-catenin were
pelleted, resuspended in buffer C [50 mM Tris–HCl
(pH 7.5), 500 mM NaCl, 1 mM TCEP, 10% glycerol, and
Complete Protease Inhibitor Cocktail EDTA-Free Tablets
(Roche)], and lysedmechanically by two passages through
a cell cracker (EmulsiFlex-C5; Avestin). The lysate was
cleared from aggregates at 45,000g for 50 min, and the
supernatant was filtered and loaded on a POROS 20MC
column. The column was equilibrated with 10 CV of
Fig. 9. Model of Axin as a highly
flexible scaffolding protein in mul-
tiple signaling pathways. AxinCR
contains overlapping binding sites
for multiple proteins acting in key
signaling pathways. Proteins that
act simultaneously through their
interaction with Axin in the Wnt
(yellow), transforming growth fac-
tor β (blue), JNK (red), and p53
(green) pathways are indicated.
782 Highly Flexible Scaffolding by Axin1buffer C, and a linear gradient between buffer C and
buffer D [50 mM Tris–HCl (pH 7.5), 500 mM NaCl, 1 mM
TCEP, 10% glycerol, and 1 M imidazole] was applied to
elute His-tagged proteins.
Interaction assays
Purified AxinCRG295-A500 was pulled down via
affinity chromatography using purified His-NusA-
GSK3β or His-β-catenin. His-NusA was used as
negative control to verify the specificity of the interac-
tion. His-AxinCRG295-A500 was used in order to examine
the possibility of AxinCRG295-A500 self-interaction. In all
assays, AxinCRG295-A500 was incubated with each
His tagged protein for 2 h at 4 °C. Samples were
loaded on gravity flow columns (Bio-Rad) with Ni2+
beads (Qiagen) equilibrated in buffer F [50 mM Tris–
HCl (pH 7.5), 100 mM NaCl, 20 mM imidazole, and
1 mM TCEP] and incubated for 1 h at 4 °C. Through
gravity flow, unbound proteins were removed, and the
beads were washed with 10 CV of buffer F. Bound
protein complexes were eluted with 4 CV of buffer G
[50 mM Tris–HCl (pH 7.5), 100 mM NaCl, 500 mM
imidazole, and 1 mM TCEP]. Samples were taken from
all steps and analyzed on SDS-PAGE.
HEK293T cells were transfected with pEBG-2T (a
mammalian GST expression vector) with or without
AxinCRG295-A500 as fused protein. Cells were lysed in
lysis buffer [50 mM Tris–HCl (pH 7.5), 100 mM NaCl,
50 mM NaF, 1% Triton, 1 mM DTT, 1 mM Na3VO4, and
protease inhibitors] at 4 °C. The soluble proteins were
separated from cell debris via centrifugation and incubat-ed with preequilibrated Glutathione Sepharose™ 4B bead
(GS-4B) slurry (GE Healthcare) for 2 h at 4 °C. The beads
were extensively washed with lysis buffer to eliminate
aspecific binding. GST fusion protein complexes were
eluted from the GS-4B beads with SDS sample buffer and
denaturation (105 °C for 5 min). Samples were taken from
all steps and analyzed by Western blot analysis.
Antibodies and siRNA
This study used mouse anti-GST antibody (Abcam),
mouse anti-β-catenin antibody (BD Transduction Labora-
tories), rabbit anti-GSK3β antibody (Cell Signaling Tech-
nology), goat anti-Axin antibody (R&D Systems), mouse–
anti-tubulin antibody (Sigma), and control siRNA and
siRNA against β-catenin (Ambion).
Silencing of β-catenin
Cells were transfected with 64 nM control siRNA or
siRNA against β-catenin. Transfection was performed
using Lipofectamine 2000 in accordance with the manu-
facturer's instructions. Forty eight hours after transfection,
cells were lysed and β-catenin levels were analyzed by
Western blot analysis.
Mammalian expression constructs and reporter assay
Human AxinCRG295-A500 was subcloned into a GST
mammalian expression vector (pEBG-2T), and full-length
783Highly Flexible Scaffolding by Axin1GST-tagged Axin was subcloned into pCS2. As mock, we
used pEBG-2T without any fused protein. HEK293T cells
were seeded in 24-well plates and cotransfected in
duplicate with 100 ng of the indicated Axin constructs
and 30 ng of the luciferase reporter construct TOPflash or
FOPflash.34 Transfection efficiency in luciferase reporter
assays was controlled and normalized by including a
constant amount of TK Renilla reporter plasmid in all
transfections. At 24 h after transfection, cells were treated
with WCM or control L-cell medium for 16 h. Cells were
lysed in passive lysis buffer (Promega), and luciferase
activities were measured with the dual-luciferase reporter
assay system (Promega) in accordance with the manufac-
turer's instructions.
Fluorometric analysis
Purified AxinCRG295-A500 (10 μM) or AxinRGS (10 μM)
in 10 mM sodium phosphate (pH 7.2), 150 mM NaCl, and
1 mM DTT was measured on a spectrophotometer
(Perkin-Elmer LS55) with a 1.5-ml cuvette (Hellma) with
a magnetic stirrer using the software Fluo_pe (D.
Veprintsev; LMB Cambridge, UK). Fluorometric analysis
was performed at increasing temperatures ranging from
20.1 °C to 80.1 °C for AxinCRG295-A500 and from 21.4 °C to
72.7 °C for AxinCR, with a 1 °C step increase. Fluorescence
was measured with excitation at 280 nm and with
emission at a range from 300 nm to 400 nm.
Analytical gel filtration
Analytical gel filtration of purified AxinCRG295-A500 at a
concentration of 500 μM was performed on an Äkta
Purifier (GE Healthcare) using a Bio-Silect SEC250
analytical column (300 mm×7.8 mm) with a guard
column (50 mm×7.8 mm; Bio-Rad) equilibrated with
25 mMTris–HCl (pH 7.2), 150 mMNaCl, and 1mMTCEP.
AxinCR was eluted at a flow rate of 1 ml/min, and the
elution profile was recorded by continuously monitoring
UV absorbance at 280 nm and 220 nm. The calibration
curve was made using molecular mass standards from a
lyophilized protein test mix (Bio-Rad), including thyro-
globulin (670 kDa), γ globulin (158 kDa), ovalbumin
(44 kDa), myoglobin (17 kDa), and vitamin B12 (1.3 kDa).
Circular dichroism
CDspectrawere recordedwith a J-810 spectropolarimeter
(Jasco). Purified AxinCRG295-A500 (40 μM) in 10 mM sodium
phosphate (pH 7.2), 50 mM NaF, and 0.5 mM TCEP was
applied on a 1-mm Quartz cell (Hellma). Far-UV spectra
were collected over a range of 190–260 nm using Jasco
software at a scanning speed of 50 nm/min and at a data
pitch of 1 nm, averaged over 10 acquisitions. Spectra were
corrected for buffer contributions. Different concentrations
of TFE were used: 10%, 20%, 30%, and 40% (vol/vol).
Disorder and secondary structure predictions
The primary protein sequence of AxinCR from Gly295
to Ala500 (GenBank accession number AAH44648.1) was
submitted to seven publicly available servers implement-ing 12 different algorithms for protein disorder prediction.
Eight publicly available algorithms were used for second-
ary structure predictions. In all cases, we used the default
parameters. The servers used are as follows: SCRATCH/
DisPro,59 DisEMBL,60 GlobPlot,61 RONN,62 DripPrep,
IUPred,63 PONDOR,64 Porter,65 HNN, SORMA, GOR4,66
PSIPRED,67 APSSP2, and PROF.68
NMR spectroscopy
15N–1H HSQC experiment was performed using
0.6 mM purified 15N-labeled AxinCRG295-A500 in buffer E
[10 mM phosphate buffer (pH 7.2), 300 mMNaCl, 0.5 mM
TCEP, 10% D2O, and 2.5% 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS)] and in buffer E plus 5 M urea. Spectra
were measured at 25 °C on a Bruker DRX600 instrument
equipped with a TCI cryoprobe. Spectra were processed
with Topspin (Bruker) and analyzed with SPARKY
software (T. D. Goddard and D. G. Keller, SPARKY 3,
University of California, San Francisco).
In vitro phosphorylation
GSK3 (7 nM; BioVision) was added to phosphorylation
buffer [50 mM Tris–HCl (pH 7.5), 100 mM NaCl, 10 mM
MgCl2, 1 mM DTT, and 10 μCi of [γ-
32P]ATP (3000 Ci/
mmol)] to phosphorylate 1μMrecombinantβ-catenin in a of
total volume of 30 μl. Samples were incubated at 30 °C for
45 min in the absence or in the presence of purified
AxinCRG295-A500, AxinCRΔβcat (G295-G430), and AxinCR-
ΔGSK3β (G433-V600) (0.1μM, 0.2μM, 0.4μM, 0.8μM, 1.6μM,
3.2 μM, 6.4 μM, 12.8 μM, and 25.6 μM). Samplesweremixed
with SDS sample buffer and loaded on gels. The gels were
dried, and a phospho imager screen (Molecular Dynamics)
was used to measure radioactivity with the Storm scanner
(Amersham Biosciences). The intensities were quantified by
ImageQuant software (Molecular Dynamics).
Acknowledgements
This work was supported by the Dutch Cancer
Society (UU 2006-3508), the European Research
Council (European Research Council starting grant
242958 to M.M.M.), the Utrecht University (High
Potential Grants to M.M.M. and S.G.D.R.), the
European Union (Marie-Curie-Excellence Grant to
S.G.D.R.), and the Netherlands Organization for
Scientific Research NWO (VIDI career development
grant to S.G.D.R.). A.F. was supported by European
Research Council starting grant 203413. We thank
Jacques P. F. Doux and Tania Rutters-Meijneke
(Biochemistry of Membranes, Bijvoet Center) for
help with CD experiments.
Supplementary Data
Supplementary data associated with this article
can be found, in the online version, at doi:10.1016/
j.jmb.2010.11.013
784 Highly Flexible Scaffolding by Axin1References
1. Logan, C. Y. & Nusse, R. (2004). The Wnt signaling
pathway in development and disease. Annu. Rev. Cell
Dev. Biol. 20, 781–810.
2. Clevers, H. (2006). Wnt/beta-catenin signaling in
development and disease. Cell, 127, 469–480.
3. MacDonald, B. T., Tamai, K. & He, X. (2009). Wnt/
beta-catenin signaling: components, mechanisms, and
diseases. Dev. Cell, 17, 9–26.
4. Kimelman, D. & Xu, W. (2006). Beta-catenin destruc-
tion complex: insights and questions from a structural
perspective. Oncogene, 25, 7482–7491.
5. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H.,
Koyama, S. & Kikuchi, A. (1998). Axin, a negative
regulator of the Wnt signaling pathway, forms a
complex with GSK-3beta and beta-catenin and pro-
motes GSK-3beta-dependent phosphorylation of beta-
catenin. EMBO J. 17, 1371–1384.
6. Sakanaka, C., Weiss, J. B. & Williams, L. T. (1998).
Bridging of beta-catenin and glycogen synthase
kinase-3beta by axin and inhibition of beta-catenin-
mediated transcription. Proc. Natl Acad. Sci. USA, 95,
3020–3023.
7. Itoh, K., Krupnik, V. E. & Sokol, S. Y. (1998). Axis
determination in Xenopus involves biochemical inter-
actions of axin, glycogen synthase kinase 3 and beta-
catenin. Curr. Biol. 8, 591–594.
8. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B.
& Polakis, P. (1998). Downregulation of beta-catenin
by human Axin and its association with the APC
tumor suppressor, beta-catenin and GSK3 beta. Curr.
Biol. 8, 573–581.
9. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler,
R. (1997). Beta-catenin is a target for the ubiquitin–
proteasome pathway. EMBO J. 16, 3797–3804.
10. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan,
Y. et al. (2002). Control of beta-catenin phosphoryla-
tion/degradation by a dual-kinase mechanism. Cell,
108, 837–847.
11. Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M.
& Byers, S. W. (1997). Serine phosphorylation-regu-
lated ubiquitination and degradation of beta-catenin.
J. Biol. Chem. 272, 24735–24738.
12. Peifer, M., Pai, L. M. & Casey, M. (1994). Phosphor-
ylation of the Drosophila adherens junction protein
Armadillo: roles for wingless signal and zeste-white 3
kinase. Dev. Biol. 166, 543–556.
13. van Noort, M., Meeldijk, J., van der Zee, R., Destree,
O. & Clevers, H. (2002). Wnt signaling controls the
phosphorylation status of beta-catenin. J. Biol. Chem.
277, 17901–17905.
14. Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S.,
Ben-Shushan, E., Mann, M. et al. (2002). Axin-
mediated CKI phosphorylation of beta-catenin at Ser
45: a molecular switch for the Wnt pathway. Genes
Dev. 16, 1066–1076.
15. Yanagawa, S., Matsuda, Y., Lee, J. S., Matsubayashi,
H., Sese, S., Kadowaki, T. & Ishimoto, A. (2002).
Casein kinase I phosphorylates the Armadillo protein
and induces its degradation inDrosophila. EMBO J. 21,
1733–1742.
16. Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U.,
Stannek, P. et al. (2005). Casein kinase 1 gammacouples Wnt receptor activation to cytoplasmic signal
transduction. Nature, 438, 867–872.
17. Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H.,
Habas, R. et al. (2005). A dual-kinase mechanism for
Wnt co-receptor phosphorylation and activation.
Nature, 438, 873–877.
18. Salahshor, S. & Woodgett, J. R. (2005). The links
between axin and carcinogenesis. J. Clin. Pathol. 58,
225–236.
19. Kim, Y. D., Park, C.H., Kim,H. S., Choi, S. K., Rew, J. S.,
Kim, D. Y. et al. (2008). Genetic alterations of Wnt
signaling pathway-associated genes in hepatocellular
carcinoma. J. Gastroenterol. Hepatol. 23, 110–118.
20. Fearnhead, N. S., Wilding, J. L., Winney, B., Tonks, S.,
Bartlett, S., Bicknell, D. C. et al. (2004). Multiple rare
variants in different genes account for multifactorial
inherited susceptibility to colorectal adenomas. Proc.
Natl Acad. Sci. USA, 101, 15992–15997.
21. Sarrio, D., Moreno-Bueno, G., Sanchez-Estevez, C.,
Banon-Rodriguez, I., Hernandez-Cortes, G., Hard-
isson, D. & Palacios, J. (2006). Expression of cadherins
and catenins correlates with distinct histologic types
of ovarian carcinomas. Hum. Pathol. 37, 1042–1049.
22. Dahmen, R. P., Koch, A., Denkhaus, D., Tonn, J. C.,
Sorensen, N., Berthold, F. et al. (2001). Deletions of
AXIN1, a component of the WNT/wingless pathway,
in sporadic medulloblastomas. Cancer Res. 61,
7039–7043.
23. McCartney, B. M. & Nathke, I. S. (2008). Cell
regulation by the APC protein Apc as master
regulator of epithelia. Curr. Opin. Cell Biol. 20,
186–193.
24. Kishida, S., Yamamoto, H., Hino, S., Ikeda, S.,
Kishida, M. & Kikuchi, A. (1999). DIX domains of
Dvl and axin are necessary for protein interactions
and their ability to regulate beta-catenin stability.Mol.
Cell. Biol. 19, 4414–4422.
25. Sakanaka, C. & Williams, L. T. (1999). Functional
domains of axin. Importance of the C terminus as an
oligomerization domain. J. Biol. Chem. 274,
14090–14093.
26. Schwarz-Romond, T., Fiedler, M., Shibata, N., Butler,
P. J., Kikuchi, A., Higuchi, Y. & Bienz, M. (2007). The
DIX domain of Dishevelled confers Wnt signaling by
dynamic polymerization. Nat. Struct. Mol. Biol. 14,
484–492.
27. Kishida, S., Yamamoto, H., Ikeda, S., Kishida, M.,
Sakamoto, I., Koyama, S. & Kikuchi, A. (1998). Axin, a
negative regulator of the Wnt signaling pathway,
directly interacts with adenomatous polyposis coli
and regulates the stabilization of beta-catenin. J. Biol.
Chem. 273, 10823–10826.
28. Hedgepeth, C. M., Deardorff, M. A., Rankin, K. &
Klein, P. S. (1999). Regulation of glycogen synthase
kinase 3beta and downstream Wnt signaling by axin.
Mol. Cell. Biol. 19, 7147–7157.
29. Hinoi, T., Yamamoto, H., Kishida, M., Takada, S.,
Kishida, S. & Kikuchi, A. (2000). Complex formation
of adenomatous polyposis coli gene product and axin
facilitates glycogen synthase kinase-3 beta-dependent
phosphorylation of beta-catenin and down-regulates
beta-catenin. J. Biol. Chem. 275, 34399–34406.
30. Yamamoto, H., Kishida, S., Kishida, M., Ikeda, S.,
Takada, S. & Kikuchi, A. (1999). Phosphorylation of
785Highly Flexible Scaffolding by Axin1axin, a Wnt signal negative regulator, by glycogen
synthase kinase-3beta regulates its stability. J. Biol.
Chem. 274, 10681–10684.
31. Spink, K. E., Polakis, P. &Weis, W. I. (2000). Structural
basis of the Axin–adenomatous polyposis coli inter-
action. EMBO J. 19, 2270–2279.
32. Dajani, R., Fraser, E., Roe, S. M., Yeo, M., Good, V. M.,
Thompson, V. et al. (2003). Structural basis for
recruitment of glycogen synthase kinase 3beta to the
axin–APC scaffold complex. EMBO J. 22, 494–501.
33. Xing, Y., Clements, W. K., Kimelman, D. & Xu, W.
(2003). Crystal structure of a beta-catenin/axin com-
plex suggests a mechanism for the beta-catenin
destruction complex. Genes Dev. 17, 2753–2764.
34. Korinek, V., Barker, N., Morin, P. J., vanWichen, D., de
Weger, R., Kinzler, K. W. et al. (1997). Constitutive
transcriptional activation by a beta-catenin–Tcf com-
plex in APC-/- colon carcinoma. Science, 275, 1784–1787.
35. Greenfield, N. J. (2006). Using circular dichroism
spectra to estimate protein secondary structure. Nat.
Protoc. 1, 2876–2890.
36. Gast, K., Zirwer, D., Muller-Frohne, M. &Damaschun,
G. (1999). Trifluoroethanol-induced conformational
transitions of proteins: insights gained from the
differences between alpha-lactalbumin and ribonucle-
ase A. Protein Sci. 8, 625–634.
37. Whitmore, L. & Wallace, B. A. (2008). Protein
secondary structure analyses from circular dichroism
spectroscopy: methods and reference databases.
Biopolymers, 89, 392–400.
38. Ferron, F., Longhi, S., Canard, B. & Karlin, D. (2006). A
practical overview of protein disorder prediction
methods. Proteins, 65, 1–14.
39. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P.,
Yang, J. Y., Chen, J. W. et al. (2008). The unfoldomics
decade: an update on intrinsically disordered pro-
teins. BMC Genomics, 9, S1.
40. Libich, D. S., Monette, M. M., Robertson, V. J. &
Harauz, G. (2007). NMR assignment of an intrinsically
disordered protein under physiological conditions:
the 18.5 kDa isoform of murine myelin basic protein.
Biomol. NMR Assign. 1, 61–63.
41. Kawahara, K. & Tanford, C. (1966). Viscosity and
density of aqueous solutions of urea and guanidine
hydrochloride. J. Biol. Chem. 241, 3228–3232.
42. Cortese, M. S., Uversky, V. N. & Dunker, A. K. (2008).
Intrinsic disorder in scaffold proteins: getting more
from less. Prog. Biophys. Mol. Biol. 98, 85–106.
43. Tompa, P. & Fuxreiter, M. (2008). Fuzzy complexes:
polymorphism and structural disorder in protein–
protein interactions. Trends Biochem. Sci. 33, 2–8.
44. Sugase, K., Dyson, H. J. & Wright, P. E. (2007).
Mechanism of coupled folding and binding of an
intrinsically disordered protein. Nature, 447,
1021–1025.
45. Boehr, D. D., Nussinov, R. & Wright, P. E. (2009). The
role of dynamic conformational ensembles in biomo-
lecular recognition. Nat. Chem. Biol. 5, 789–796.
46. Luo, W. & Lin, S. C. (2004). Axin: a master scaffold for
multiple signaling pathways.Neurosignals, 13, 99–113.
47. Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M.
et al. (2006). Axin is a scaffold protein in TGF-beta
signaling that promotes degradation of Smad7 by
Arkadia. EMBO J. 25, 1646–1658.48. Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X. &
Wang, X. F. (2008). Axin and GSK3-control Smad3
protein stability and modulate TGF-signaling. Genes
Dev. 22, 106–120.
49. Rui, Y., Xu, Z., Lin, S., Li, Q., Rui, H., Luo, W. et al.
(2004). Axin stimulates p53 functions by activation of
HIPK2 kinase through multimeric complex formation.
EMBO J. 23, 4583–4594.
50. Li, Q., Wang, X., Wu, X., Rui, Y., Liu, W., Wang, J.
et al. (2007). Daxx cooperates with the Axin/HIPK2/
p53 complex to induce cell death. Cancer Res. 67,
66–74.
51. Li, Q., Lin, S., Wang, X., Lian, G., Lu, Z., Guo, H. et al.
(2009). Axin determines cell fate by controlling the p53
activation threshold after DNA damage. Nat. Cell Biol.
11, 1128–1134.
52. Lee, E., Salic, A., Kruger, R., Heinrich, R. & Kirschner,
M.W. (2003). The roles of APC and Axin derived from
experimental and theoretical analysis of the Wnt
pathway. PLoS Biol. 1, E10.
53. Hilser, V. J. & Thompson, E. B. (2007). Intrinsic
disorder as a mechanism to optimize allosteric
coupling in proteins. Proc. Natl Acad. Sci. USA, 104,
8311–8315.
54. Luo, W., Ng, W. W., Jin, L. H., Ye, Z., Han, J. & Lin,
S. C. (2003). Axin utilizes distinct regions for
competitive MEKK1 and MEKK4 binding and JNK
activation. J. Biol. Chem. 278, 37451–37458.
55. Liu, J., Xing, Y., Hinds, T. R., Zheng, J. & Xu, W.
(2006). The third 20 amino acid repeat is the tightest
binding site of APC for beta-catenin. J. Mol. Biol. 360,
133–144.
56. Tompa, P., Fuxreiter, M., Oldfield, C. J., Simon, I.,
Dunker, A. K. & Uversky, V. N. (2009). Close
encounters of the third kind: disordered domains
and the interactions of proteins. BioEssays, 31,
328–335.
57. Martin, J. & Dufour, J. F. (2008). Tumor suppressor
and hepatocellular carcinoma. World J. Gastroenterol.
14, 1720–1733.
58. Cabrita, L. D., Gilis, D., Robertson, A. L., Dehouck, Y.,
Rooman, M. & Bottomley, S. P. (2007). Enhancing the
stability and solubility of TEV protease using in silico
design. Protein Sci. 16, 2360–2367.
59. Cheng, J., Randall, A. Z., Sweredoski, M. J. & Baldi, P.
(2005). SCRATCH: a protein structure and structural
feature prediction server. Nucleic Acids Res. 33,
W72–W76.
60. Linding, R., Jensen, L. J., Diella, F., Bork, P., Gibson,
T. J. & Russell, R. B. (2003). Protein disorder
prediction: implications for structural proteomics.
Structure, 11, 1453–1459.
61. Linding, R., Russell, R. B., Neduva, V. & Gibson, T. J.
(2003). GlobPlot: exploring protein sequences for
globularity and disorder. Nucleic Acids Res. 31,
3701–3708.
62. Yang, Z. R., Thomson, R., McNeil, P. & Esnouf,
R. M. (2005). RONN: the bio-basis function neural
network technique applied to the detection of
natively disordered regions in proteins. Bioinfor-
matics, 21, 3369–3376.
63. Dosztanyi, Z., Csizmok, V., Tompa, P. & Simon, I.
(2005). IUPred: web server for the prediction of
intrinsically unstructured regions of proteins based
786 Highly Flexible Scaffolding by Axin1on estimated energy content. Bioinformatics, 21,
3433–3434.
64. Romero, P., Obradovic, Z., Li, X., Garner, E. C.,
Brown, C. J. & Dunker, A. K. (2001). Sequence
complexity of disordered protein. Proteins, 42, 38–48.
65. Pollastri, G. & McLysaght, A. (2005). Porter: a new,
accurate server for protein secondary structure pre-
diction. Bioinformatics, 21, 1719–1720.66. Combet, C., Blanchet, C., Geourjon, C. & Deleage, G.
(2000). NPS@: network protein sequence analysis.
Trends Biochem. Sci. 25, 147–150.
67. Jones, D. T. (1999). Protein secondary structure
prediction based on position-specific scoring matrices.
J. Mol. Biol. 292, 195–202.
68. Rost, B., Yachdav, G. & Liu, J. (2004). The PredictPro-
tein server. Nucleic Acids Res. 32, W321–W326.
